Incannex Healthcare Inc. financial data

Symbol
IXHL on Nasdaq
Location
Norwest Nsw
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 13 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1075% % 335%
Debt-to-equity 11% % -87%
Return On Equity -113% % 61%
Return On Assets -102% % 34%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 358,329,368 shares 1906%
Common Stock, Shares, Outstanding 359,218,871 shares 1920%
Entity Public Float $29,100,000 USD -55%
Common Stock, Value, Issued $36,000 USD 1700%
Weighted Average Number of Shares Outstanding, Basic 349,464,317 shares 1883%
Weighted Average Number of Shares Outstanding, Diluted 349,464,317 shares 1883%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $12,000 USD
Research and Development Expense $9,837,000 USD -18%
General and Administrative Expense $16,483,000 USD -0.58%
Operating Income (Loss) $26,320,000 USD 7.4%
Nonoperating Income (Expense) $22,179,000 USD -577%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $48,499,000 USD -104%
Net Income (Loss) Attributable to Parent $48,499,000 USD -104%
Earnings Per Share, Basic -0.77 USD/shares 43%
Earnings Per Share, Diluted -0.77 USD/shares 43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $68,900,000 USD 3184%
Assets, Current $74,678,000 USD 611%
Property, Plant and Equipment, Net $108,000 USD -60%
Operating Lease, Right-of-Use Asset $163,000 USD -50%
Assets $75,006,000 USD 575%
Employee-related Liabilities, Current $48,000 USD -87%
Accrued Liabilities, Current $133,000 USD -96%
Contract with Customer, Liability, Current $30,000 USD 11%
Liabilities, Current $1,547,000 USD -74%
Operating Lease, Liability, Noncurrent $53,000 USD -65%
Liabilities $1,600,000 USD -84%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,188,000 USD 6.4%
Retained Earnings (Accumulated Deficit) $170,484,000 USD -40%
Stockholders' Equity Attributable to Parent $73,406,000 USD 7515%
Liabilities and Equity $75,006,000 USD 575%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,163,000 USD -308%
Net Cash Provided by (Used in) Financing Activities $67,177,000 USD
Net Cash Provided by (Used in) Investing Activities $42,000 USD
Common Stock, Shares Authorized 800,000,000 shares 700%
Common Stock, Shares, Issued 359,218,871 shares 1920%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,231,000 USD 62%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $69,193,000 USD 3198%
Operating Lease, Liability $163,000 USD -50%
Depreciation $66,000,000 USD -0.28%
Payments to Acquire Property, Plant, and Equipment $2,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $48,280,000 USD -98%
Lessee, Operating Lease, Liability, to be Paid $176,000 USD -52%
Property, Plant and Equipment, Gross $506,000 USD -9.6%
Operating Lease, Liability, Current $110,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year Two $33,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year One $49,000 USD -74%
Operating Lease, Weighted Average Discount Rate, Percent 0.0918 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $13,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid, Year Three $32,000 USD -82%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $11,790,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid, Year Four $38,000 USD
Additional Paid in Capital $247,042,000 USD 96%
Share-based Payment Arrangement, Expense $1,402,000 USD -129%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%